Just wondering, there's this hype around cyramza's approval for CRC in addition to Folfiri but it says "Cyramza showed promising results in the phase 3 RAISE trial that led to its approval, extending overall survival by 1.6 months and progression-free survival by 2.2 months compared with FOLFIR...